Cargando…
Neuer Masterstudiengang: Multiple Sklerose Management
The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807678/ https://www.ncbi.nlm.nih.gov/pubmed/35107651 http://dx.doi.org/10.1007/s10354-021-00900-3 |
_version_ | 1784643734642622464 |
---|---|
author | Voigt, Isabel Stadelmann, Christine Meuth, Sven G. Schipp, Bernhard Flachenecker, Peter Mäurer, Mathias Funk, Richard H. W. Ramisch, Franziska Niemeier, Joachim Ziemssen, Tjalf |
author_facet | Voigt, Isabel Stadelmann, Christine Meuth, Sven G. Schipp, Bernhard Flachenecker, Peter Mäurer, Mathias Funk, Richard H. W. Ramisch, Franziska Niemeier, Joachim Ziemssen, Tjalf |
author_sort | Voigt, Isabel |
collection | PubMed |
description | The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s program offered by Dresden International University (DIU) since 2020. Over a period of four semesters, it can be completed part-time and largely digitally. The master’s program is divided into six modules focusing on basics, clinical and diagnostic aspects, MS studies and statistics, disease-modifying and symptomatic therapy, disease monitoring and documentation. The teaching includes theoretical parts and numerous practical units. A further goal is to derive therapeutic intervention plans and problem-solving strategies from scientific publications and clinical studies, to develop them further and to apply them in patient care. The lecturers come from Germany, Austria and Switzerland and are predominantly professors. The German Multiple Sclerosis Society is the patron of the course. This article presents the study program in detail. |
format | Online Article Text |
id | pubmed-8807678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-88076782022-02-02 Neuer Masterstudiengang: Multiple Sklerose Management Voigt, Isabel Stadelmann, Christine Meuth, Sven G. Schipp, Bernhard Flachenecker, Peter Mäurer, Mathias Funk, Richard H. W. Ramisch, Franziska Niemeier, Joachim Ziemssen, Tjalf Wien Med Wochenschr Themenschwerpunkt The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s program offered by Dresden International University (DIU) since 2020. Over a period of four semesters, it can be completed part-time and largely digitally. The master’s program is divided into six modules focusing on basics, clinical and diagnostic aspects, MS studies and statistics, disease-modifying and symptomatic therapy, disease monitoring and documentation. The teaching includes theoretical parts and numerous practical units. A further goal is to derive therapeutic intervention plans and problem-solving strategies from scientific publications and clinical studies, to develop them further and to apply them in patient care. The lecturers come from Germany, Austria and Switzerland and are predominantly professors. The German Multiple Sclerosis Society is the patron of the course. This article presents the study program in detail. Springer Vienna 2022-02-02 2022 /pmc/articles/PMC8807678/ /pubmed/35107651 http://dx.doi.org/10.1007/s10354-021-00900-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Themenschwerpunkt Voigt, Isabel Stadelmann, Christine Meuth, Sven G. Schipp, Bernhard Flachenecker, Peter Mäurer, Mathias Funk, Richard H. W. Ramisch, Franziska Niemeier, Joachim Ziemssen, Tjalf Neuer Masterstudiengang: Multiple Sklerose Management |
title | Neuer Masterstudiengang: Multiple Sklerose Management |
title_full | Neuer Masterstudiengang: Multiple Sklerose Management |
title_fullStr | Neuer Masterstudiengang: Multiple Sklerose Management |
title_full_unstemmed | Neuer Masterstudiengang: Multiple Sklerose Management |
title_short | Neuer Masterstudiengang: Multiple Sklerose Management |
title_sort | neuer masterstudiengang: multiple sklerose management |
topic | Themenschwerpunkt |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807678/ https://www.ncbi.nlm.nih.gov/pubmed/35107651 http://dx.doi.org/10.1007/s10354-021-00900-3 |
work_keys_str_mv | AT voigtisabel neuermasterstudiengangmultiplesklerosemanagement AT stadelmannchristine neuermasterstudiengangmultiplesklerosemanagement AT meuthsveng neuermasterstudiengangmultiplesklerosemanagement AT schippbernhard neuermasterstudiengangmultiplesklerosemanagement AT flacheneckerpeter neuermasterstudiengangmultiplesklerosemanagement AT maurermathias neuermasterstudiengangmultiplesklerosemanagement AT funkrichardhw neuermasterstudiengangmultiplesklerosemanagement AT ramischfranziska neuermasterstudiengangmultiplesklerosemanagement AT niemeierjoachim neuermasterstudiengangmultiplesklerosemanagement AT ziemssentjalf neuermasterstudiengangmultiplesklerosemanagement |